{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:36:23Z","timestamp":1787240183158,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T00:00:00Z","timestamp":1420416000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Outcome measures are crucial in assessing an autoimmune blistering disease's (\n                    <jats:styled-content style=\"fixed-case\">AIBD<\/jats:styled-content>\n                    ) severity as well as its impact on the patient's quality of life (\n                    <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>\n                    ). The standardization of\n                    <jats:styled-content style=\"fixed-case\">AIBD<\/jats:styled-content>\n                    outcome measures is pivotal to accurately monitor the patient and to pool results from randomized controlled trials for meta\u2010analysis, and thereby provide knowledge of the optimal\n                    <jats:styled-content style=\"fixed-case\">AIBD<\/jats:styled-content>\n                    therapies. In the past decade, several\n                    <jats:styled-content style=\"fixed-case\">AIBD<\/jats:styled-content>\n                    severity outcome measures have been developed and validated. For pemphigus severity, the Pemphigus Disease Area Index (\n                    <jats:styled-content style=\"fixed-case\">PDAI<\/jats:styled-content>\n                    ) developed by the International Pemphigus Definitions Group was shown to be the most superior, followed by the Autoimmune Bullous Skin Disorder Intensity Score (\n                    <jats:styled-content style=\"fixed-case\">ABSIS<\/jats:styled-content>\n                    ) by the German group. For bullous pemphigoid severity, the Bullous Pemphigoid Disease Area Index (\n                    <jats:styled-content style=\"fixed-case\">BPDAI<\/jats:styled-content>\n                    ) was shown to be an accurate and valid measure. To quantify the burden of\n                    <jats:styled-content style=\"fixed-case\">AIBD<\/jats:styled-content>\n                    and its treatments on\n                    <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>\n                    , the Autoimmune Bullous Disease Quality of Life (\n                    <jats:styled-content style=\"fixed-case\">ABQOL<\/jats:styled-content>\n                    ) and the Treatment of Autoimmune Bullous Disease Quality of Life (\n                    <jats:styled-content style=\"fixed-case\">TABQOL<\/jats:styled-content>\n                    ) were also developed, validated, and are now being validated in multiple languages and cultures.\n                  <\/jats:p>","DOI":"10.1111\/1346-8138.12711","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T05:11:10Z","timestamp":1420434670000},"page":"31-36","source":"Crossref","is-referenced-by-count":34,"title":["Outcome measures for autoimmune blistering diseases"],"prefix":"10.1111","volume":"42","author":[{"given":"Cathy Y.","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Medicine University of New South Wales Sydney New South Wales Australia"},{"name":"Department of Dermatology St George Hospital Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[{"name":"Department of Medicine University of New South Wales Sydney New South Wales Australia"},{"name":"Department of Dermatology St George Hospital Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,5]]},"reference":[{"issue":"1","key":"e_1_2_9_2_1","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin LK","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.017"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02501.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(74)90365-X"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.72"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.8179"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02218.x"},{"key":"e_1_2_9_10_1","first-page":"158","article-title":"Pemphigus Area and Activity Score (PAAS)\u2013a novel clinical scoring method for monitoring of pemphigus vulgaris patients","volume":"37","author":"Agarwal M","year":"1998","journal-title":"Int J Dermatol"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-002-0367-2"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04132.x"},{"issue":"1","key":"e_1_2_9_13_1","first-page":"4","article-title":"Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus","volume":"17","author":"Pfutze M","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01811.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.02.011"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1666"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.8175"},{"issue":"4","key":"e_1_2_9_18_1","first-page":"224","article-title":"Pemphigus vulgaris activity score and assessment of convergent validity","volume":"51","author":"Chams\u2010Davatchi C","year":"2013","journal-title":"Acta Med Iran"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09300.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a180"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/854795"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700958"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000362717"},{"key":"e_1_2_9_26_1","unstructured":"WijayantiA ZhaoCY BoettigerD IshiiN HashimotoT MurrellDF.The Validity Reliability and Responsiveness of the Bullous Pemphigoid Disease Area Index (BPDAI). Cutaneous Biologic Meeting; 22\u201326 Sep 2014 North Stradbroke Island. North Stradbroke Island: Australasian Society of Dermatological Research 2014. Available fromhttp:\/\/cutaneous-2014.p.asnevents.com.au\/schedule\/abstract\/18743[accessed on 26 September 2014]."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.171"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12041"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.009"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.016"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12836"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12623"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb04192.x"},{"key":"e_1_2_9_34_1","unstructured":"DF Sebaratnam DF Murrell V Werth 2014 Paper presented at Medical Dermatology Society Annual Meeting Denver"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1346-8138.12711","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.12711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:23:32Z","timestamp":1694636612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.12711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/1346-8138.12711"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.12711","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}